Literature DB >> 22820625

Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.

Swetha Sundararajan1, Subash Babu, Sulochana D Das.   

Abstract

The interaction of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and pro-inflammatory cytokines in response to Mycobacterium tuberculosis (MTB) infection is important to understand the immune response at the site of infection. We compared the levels of MMPs, TIMPs and cytokines in plasma (BL) and pleural fluid (PF) of tuberculosis (TB) and non tuberculosis (NTB) patients. Comparison between BL and PF showed significantly higher levels of MMP-1, TIMP-1 and -3 in TB PF; of MMP-7, -8, -9 in BL of both groups. Also, levels of MMP-1,-8,-9 and TIMP-3 were significantly higher in TB PF compared to NTB. Cytokines INF-γ, TNF-α, and IL-6 significantly increased in PF of both groups. A positive correlation of MMPs with TIMPs in TB, MMP-1 and -9 with IL-6 in TB PF and MMP-9 with IFN-γ in NTB PF was observed. This study implicates the possible usage of MMPs as bio-markers aiding diagnosis in TB pleuritis.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820625      PMCID: PMC3511911          DOI: 10.1016/j.humimm.2012.07.042

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  35 in total

Review 1.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Authors:  Andrew H Baker; Dylan R Edwards; Gillian Murphy
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

2.  Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients.

Authors:  E Hrabec; M Strek; M Zieba; S Kwiatkowska; Z Hrabec
Journal:  Int J Tuberc Lung Dis       Date:  2002-08       Impact factor: 2.373

3.  TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells.

Authors:  M R Smith; H Kung; S K Durum; N H Colburn; Y Sun
Journal:  Cytokine       Date:  1997-10       Impact factor: 3.861

4.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases.

Authors:  J C Chang; A Wysocki; K M Tchou-Wong; N Moskowitz; Y Zhang; W N Rom
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 5.  Tuberculous pleurisy.

Authors:  H W Berger; E Mejia
Journal:  Chest       Date:  1973-01       Impact factor: 9.410

6.  TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages.

Authors:  P Sarén; H G Welgus; P T Kovanen
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

7.  MMP and TIMP expression pattern in pleural effusions of different origins.

Authors:  O Eickelberg; C O Sommerfeld; C Wyser; M Tamm; F Reichenberger; P G Bardin; M Solèr; M Roth; A P Perruchoud
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

8.  Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA).

Authors:  M Lotz; P A Guerne
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

9.  Matrilysin expression and function in airway epithelium.

Authors:  S E Dunsmore; U K Saarialho-Kere; J D Roby; C L Wilson; L M Matrisian; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

10.  Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

Authors:  A H Baker; S J George; A B Zaltsman; G Murphy; A C Newby
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  18 in total

1.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

2.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

3.  Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children.

Authors:  Nathella Pavan Kumar; R Anuradha; Bruno B Andrade; N Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2013-03-13

Review 4.  Macrophages in tuberculosis: friend or foe.

Authors:  Evelyn Guirado; Larry S Schlesinger; Gilla Kaplan
Journal:  Semin Immunopathol       Date:  2013-07-18       Impact factor: 9.623

5.  Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.

Authors:  Lisete Ribeiro Teixeira; Murilo B Dias; Roberta K B Sales; Leila Antonangelo; Vanessa A Alvarenga; Juliana Puka; Evaldo Marchi; Milena Marques Pagliarelli Acencio
Journal:  Lung       Date:  2016-09-27       Impact factor: 2.584

6.  Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Eduardo P Amaral; Nicolas Riteau; Katrin D Mayer-Barber; Kevin W Tosh; Nolan Maier; Elisabete L Conceição; Andre Kubler; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Theolis Barbosa; Vincent C Manganiello; Joel Moss; Joseph R Fontana; Beatriz E Marciano; Elizabeth P Sampaio; Kenneth N Olivier; Steven M Holland; Sharon H Jackson; Mahtab Moayeri; Stephen Leppla; Irini Sereti; Daniel L Barber; Thomas B Nutman; Subash Babu; Alan Sher
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

7.  Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Vijay Viswanathan; Shanmugam Sivakumar; Syed Hissar; Hardy Kornfeld; Subash Babu
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-04-22

8.  Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study.

Authors:  Selvakumar Subbian; Liana Tsenova; Mi-Jeong Kim; Helen C Wainwright; Annalie Visser; Nirmalya Bandyopadhyay; Joel S Bader; Petros C Karakousis; Gabriele B Murrmann; Linda-Gail Bekker; David G Russell; Gilla Kaplan
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

9.  Calpain and spectrin breakdown products as potential biomarkers in tuberculous pleural effusion.

Authors:  Ji Young Hong; So Yeong Park; Youngmi Kim; Chang Youl Lee; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study.

Authors:  Meng-Rui Lee; Chia-Jung Tsai; Wei-Jie Wang; Tzu-Yi Chuang; Chih-Mann Yang; Lih-Yu Chang; Ching-Kai Lin; Jann-Yuan Wang; Chin-Chong Shu; Li-Na Lee; Chong-Jen Yu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.